244 related articles for article (PubMed ID: 23537858)
21. Copy number changes of the microcephalin 1 gene (MCPH1) in patients with autism spectrum disorders.
Ozgen HM; van Daalen E; Bolton PF; Maloney VK; Huang S; Cresswell L; van den Boogaard MJ; Eleveld MJ; van 't Slot R; Hochstenbach R; Beemer FA; Barrow M; Barber JC; Poot M
Clin Genet; 2009 Oct; 76(4):348-56. PubMed ID: 19793310
[TBL] [Abstract][Full Text] [Related]
22. De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment.
Hamdan FF; Daoud H; Rochefort D; Piton A; Gauthier J; Langlois M; Foomani G; Dobrzeniecka S; Krebs MO; Joober R; Lafrenière RG; Lacaille JC; Mottron L; Drapeau P; Beauchamp MH; Phillips MS; Fombonne E; Rouleau GA; Michaud JL
Am J Hum Genet; 2010 Nov; 87(5):671-8. PubMed ID: 20950788
[TBL] [Abstract][Full Text] [Related]
23. Familial KANK1 deletion that does not follow expected imprinting pattern.
Vanzo RJ; Martin MM; Sdano MR; South ST
Eur J Med Genet; 2013 May; 56(5):256-9. PubMed ID: 23454270
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: a gradient of severity in cognitive impairments.
Leblond CS; Nava C; Polge A; Gauthier J; Huguet G; Lumbroso S; Giuliano F; Stordeur C; Depienne C; Mouzat K; Pinto D; Howe J; Lemière N; Durand CM; Guibert J; Ey E; Toro R; Peyre H; Mathieu A; Amsellem F; Rastam M; Gillberg IC; Rappold GA; Holt R; Monaco AP; Maestrini E; Galan P; Heron D; Jacquette A; Afenjar A; Rastetter A; Brice A; Devillard F; Assouline B; Laffargue F; Lespinasse J; Chiesa J; Rivier F; Bonneau D; Regnault B; Zelenika D; Delepine M; Lathrop M; Sanlaville D; Schluth-Bolard C; Edery P; Perrin L; Tabet AC; Schmeisser MJ; Boeckers TM; Coleman M; Sato D; Szatmari P; Scherer SW; Rouleau GA; Betancur C; Leboyer M; Gillberg C; Delorme R; Bourgeron T
PLoS Genet; 2014 Sep; 10(9):e1004580. PubMed ID: 25188300
[TBL] [Abstract][Full Text] [Related]
25. Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder.
Talkowski ME; Mullegama SV; Rosenfeld JA; van Bon BW; Shen Y; Repnikova EA; Gastier-Foster J; Thrush DL; Kathiresan S; Ruderfer DM; Chiang C; Hanscom C; Ernst C; Lindgren AM; Morton CC; An Y; Astbury C; Brueton LA; Lichtenbelt KD; Ades LC; Fichera M; Romano C; Innis JW; Williams CA; Bartholomew D; Van Allen MI; Parikh A; Zhang L; Wu BL; Pyatt RE; Schwartz S; Shaffer LG; de Vries BB; Gusella JF; Elsea SH
Am J Hum Genet; 2011 Oct; 89(4):551-63. PubMed ID: 21981781
[TBL] [Abstract][Full Text] [Related]
26. [Diagnostics of the genetic causes of autism spectrum disorders - a clinical geneticist's view].
Szczaluba K
Psychiatr Pol; 2014; 48(4):677-88. PubMed ID: 25314796
[TBL] [Abstract][Full Text] [Related]
27. [Autism spectrum disorder and genes for synaptic proteins].
Shishido E
Brain Nerve; 2012 Jan; 64(1):65-70. PubMed ID: 22223503
[TBL] [Abstract][Full Text] [Related]
28. Epilepsy and mental retardation limited to females with PCDH19 mutations can present de novo or in single generation families.
Hynes K; Tarpey P; Dibbens LM; Bayly MA; Berkovic SF; Smith R; Raisi ZA; Turner SJ; Brown NJ; Desai TD; Haan E; Turner G; Christodoulou J; Leonard H; Gill D; Stratton MR; Gecz J; Scheffer IE
J Med Genet; 2010 Mar; 47(3):211-6. PubMed ID: 19752159
[TBL] [Abstract][Full Text] [Related]
29. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy.
Courcet JB; Faivre L; Malzac P; Masurel-Paulet A; Lopez E; Callier P; Lambert L; Lemesle M; Thevenon J; Gigot N; Duplomb L; Ragon C; Marle N; Mosca-Boidron AL; Huet F; Philippe C; Moncla A; Thauvin-Robinet C
J Med Genet; 2012 Dec; 49(12):731-6. PubMed ID: 23099646
[TBL] [Abstract][Full Text] [Related]
30. Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency.
Berryer MH; Hamdan FF; Klitten LL; Møller RS; Carmant L; Schwartzentruber J; Patry L; Dobrzeniecka S; Rochefort D; Neugnot-Cerioli M; Lacaille JC; Niu Z; Eng CM; Yang Y; Palardy S; Belhumeur C; Rouleau GA; Tommerup N; Immken L; Beauchamp MH; Patel GS; Majewski J; Tarnopolsky MA; Scheffzek K; Hjalgrim H; Michaud JL; Di Cristo G
Hum Mutat; 2013 Feb; 34(2):385-94. PubMed ID: 23161826
[TBL] [Abstract][Full Text] [Related]
31. Role of metabotropic glutamate receptor 7 in autism spectrum disorders: a pilot study.
Yang Y; Pan C
Life Sci; 2013 Feb; 92(2):149-53. PubMed ID: 23201551
[TBL] [Abstract][Full Text] [Related]
32. Autism spectrum disorders and epilepsy: moving towards a comprehensive approach to treatment.
Tuchman R; Alessandri M; Cuccaro M
Brain Dev; 2010 Oct; 32(9):719-30. PubMed ID: 20558021
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of autism spectrum disorder in Cornelia de Lange syndrome.
Moss J; Howlin P; Magiati I; Oliver C
J Child Psychol Psychiatry; 2012 Aug; 53(8):883-91. PubMed ID: 22490014
[TBL] [Abstract][Full Text] [Related]
34. [The influence of genes and environment on the development of autism spectrum disorders].
Spek AA
Tijdschr Psychiatr; 2014; 56(10):660-7. PubMed ID: 25327347
[TBL] [Abstract][Full Text] [Related]
35. De novo and rare inherited mutations implicate the transcriptional coregulator TCF20/SPBP in autism spectrum disorder.
Babbs C; Lloyd D; Pagnamenta AT; Twigg SR; Green J; McGowan SJ; Mirza G; Naples R; Sharma VP; Volpi EV; Buckle VJ; Wall SA; Knight SJ; ; Parr JR; Wilkie AO
J Med Genet; 2014 Nov; 51(11):737-47. PubMed ID: 25228304
[TBL] [Abstract][Full Text] [Related]
36. Microdeletion and microduplication syndromes.
Vissers LE; Stankiewicz P
Methods Mol Biol; 2012; 838():29-75. PubMed ID: 22228006
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of autism spectrum disorder among Nigerian children with intellectual disability: a stopgap assessment.
Bakare MO; Ebigbo PO; Ubochi VN
J Health Care Poor Underserved; 2012 May; 23(2):513-8. PubMed ID: 22643602
[TBL] [Abstract][Full Text] [Related]
38. Autism spectrum disorders: molecular genetic advances.
Bacchelli E; Maestrini E
Am J Med Genet C Semin Med Genet; 2006 Feb; 142C(1):13-23. PubMed ID: 16419096
[TBL] [Abstract][Full Text] [Related]
39. Special Report: Chromosomal Microarray for the Genetic Evaluation of Patients With Global Developmental Delay, Intellectual Disability, and Autism Spectrum Disorder.
Blue Cross Blue Shield Asssociation
Technol Eval Cent Assess Program Exec Summ; 2015 Aug; 30(2):1-4. PubMed ID: 26376503
[No Abstract] [Full Text] [Related]
40. Characterisation of CASPR2 deficiency disorder--a syndrome involving autism, epilepsy and language impairment.
Rodenas-Cuadrado P; Pietrafusa N; Francavilla T; La Neve A; Striano P; Vernes SC
BMC Med Genet; 2016 Feb; 17():8. PubMed ID: 26843181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
